Latest Inhaler Stories
LONDON, March 24, 2015 /PRNewswire/ -- Key Findings--Chronic obstructive pulmonary disorder (COPD) is the third leading cause of death in the United States, and is in fourth
RICHMOND, Va., March 16, 2015 /PRNewswire/ -- On Friday, the FDA listed Kitabis(TM) Pak as a therapeutic equivalent of TOBI(®) (tobramycin inhalation solution, USP) in their Orange
MUMBAI and BALTIMORE, USA, February 18, 2015 /PRNewswire/ -- Pharma Major Lupin Limited announced today that its US subsidiary, Lupin Pharmaceuticals Inc.
RICHMOND, Va., Feb. 11, 2015 /PRNewswire/ -- The first patient has been enrolled in the PARI PROVIDE compressor access program to accompany the launch of Kitabis Pak.
- Divestiture permits Actavis to enhance focus on core strategic therapeutic categories - DUBLIN, Feb.
Topical market research report “PharmaPoint: Asthma - Global Drug Forecast and Market Analysis to 2023” elaborated by GlobalData has been recently published at MarketPublishers.com.
Seventy-eight cardiovascular and pulmonary rehabilitation professionals completed a survey about treatments for breathing disorders.
-- World's first NZ study of novel SmartTrack Inhaler on 220 children MELBOURNE, Asutralia, Jan.
RnRMarketResearch.com adds "Global and Chinese Inhalers Industry, 2009-2019 Market Research Report" to its store. DALLAS, Jan.
More Images (2 images) »